Recurrent acute thrombocytopenia in the hospitalized patient: Sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia

American Journal of Hematology

Volumn 85, Issue 1, 2010, Pages 71-74

  Rousan, Talla A ^a   Aldoss, Ibrahim T ^b   Cowley Jr , Benjamin D ^a   Curtis, Brian R ^c   Bougie, Daniel W ^c   Aster, Richard H ^c   George, James N ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMLODIPINE; BACITRACIN; CALCIUM ACETATE; CIPROFLOXACIN; CLONIDINE; CYANOCOBALAMIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DIPHENHYDRAMINE; ERYTHROPOIETIN; GABAPENTIN; GENTAMICIN; HEPARIN; HYDRALAZINE; HYDROMORPHONE; ISOSORBIDE; LABETALOL; LISINOPRIL; MORPHINE; ONDANSETRON; PANTOPRAZOLE; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; POLYSTYRENESULFONATE SODIUM; PROMETHAZINE; QUETIAPINE; SERTRALINE; VANCOMYCIN; ANTIINFECTIVE AGENT; PIPERACILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CASE REPORT; CELL STRUCTURE; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT INFECTION; HEMODIALYSIS; HOSPITAL PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY DYSPLASIA; KIDNEY FAILURE; LABORATORY TEST; MALE; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; BACTEREMIA; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DRUG HYPERSENSITIVITY; IMMUNOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG HYPERSENSITIVITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PIPERACILLIN; THROMBOCYTOPENIA;

EID: 74049095560     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21536     Document Type: Article

References (22)

1. Warkentin TE. Think if HIT. In: Berliner N, Linker C, Schiffer CA, editors. Hematology 2006. Washington, D.C.: American Society of Hematology; 2006. pp 408-414.
2. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Int Med 1998;129:886-990.
3. Pérez-Vázquez A, Pastor JM, Riancho JA. Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis 1998;27:650-651.
4. Olivera E, Lakhani P, Watanakunakorn C. Isolated severe thrombocytopenia and bleeding caused by piperacillin. Scand J Infect Dis 1992;24:815-817.
5. Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug- specific" antibodies. Blood 2006;108:922-927.
6. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-587.
7. Aster RH, Curtis BR, Mcfarland JG, Bougie DW. Durg-induced immune thrombocytopenia: Pathogenesis, diagnosis and management. J Thromb Haemost 2009;7:911-918.
8. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714-2718.
9. Belkin GA. Cocktail purpura: An unusual case of quinine sensitivity. Ann Intern Med 1967;66:583.
10. Kojouri K, Perdue JJ, Medina PJ, George JN. Occult quinine-induced thrombocytopenia. J Okla State Med Assoc 2000;93:519-521.
11. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: A great imitator. Arch Intern Med 2004;164:218-220.
12. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone survey. JAMA 2002;287:337-344.
13. Von Drygalski A, Curtis BR, Bougie DW, Mcfarland JG, Ahl S, Limbu I, Baker KR, Aster RH. Vancomycin-induced immune thrombocytopenia. N Engl J Med 2007;356:904-910.
14. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PRA. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients. Br J Haematol 2003;122:966-974.
15. Young M, Plosker GL. Piperacillin/Tazobactam. A pharmacoeconomic review of its use in moderate to severe bacterial infections. Pharmacoeconomics 2001;19:1135-1175.
16. Petri WA. Penicillins, cephalosporines and other lactam antibiotics. In: Brunton LL, Lazo JS, Parker KR, editors. The Pharmacologic Basis of Therapeutics, 11th ed. New York: McGraw-Hill; 2006. pp 1127-1154.
17. Arndt PA, Garratty G, Hill J, Kasper M, Chandrasekaran V. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method. Vox Sang 2002;83:273-278.
18. Leger RM, Arndt PA, Garratty G. Serologic studies of piperacillin antibodies. Transfusion 2008;48:2429-2434.
19. Park BK, Kitteringham NR, Powell H, Pirmohamed M. Advances in molecular toxicology - Towards understanding idiosyncratic drug toxicity. Toxicology 2000;153:39-60.
20. Shulman NR. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 1964;60:506-521.
21. Azuno Y, Yaga K, Sasayama T, Kimoto K. Thrombocytopenia induced byJui, a traditional Chinese herbal medicine. Lancet 1999;354:304-305.
22. Ohmori T, Nishii K, Hagihara A, Takeda M, Sekido K. Acute thrombocytopenia induced byJui, a traditional herbal medicine. J Thromb Haemost 2004;2: 1479-1480.